Genetic Marker Enables Better Prediction of Warfarin Dose in Patients of African Ancestry

A new-found genetic marker promises to better predict warfarin dose in African Americans, according to a study published online in The Lancet. If confirmed in further studies, the finding may help to avert more of the bleeds and blood clots that come when a patients's starting dose misses the drug's narrow safety window. To read the full story click below:

http://www.uab.edu/news/latest/item/3520-genetic-marker-enables-better-prediction-of-warfarin-dose-in-patients-of-african-ancestry